DIRECTOR/PDMR SHAREHOLDINGS
Vesting of Replacement Award
As previously announced on
The following notifications are made in accordance with DTR 3.1.2-A, incorporating article 19(1) of the Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
|
a) |
|
|
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
Chief Financial Officer |
||||||
|
b) |
Initial notification/ |
Initial notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
|
|
||||||
|
b) |
LEI |
5493003JFSMOJG48V108 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in
GB00B24CGK77 |
||||||
|
b) |
Nature of the transaction |
Vesting of replacement share awards in relation to former employment with NIKE, Inc and accrual of dividend equivalent shares. |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information Aggregated volume Price |
N/A
|
||||||
|
e) |
Date of the transaction |
2025-08-01 |
||||||
|
f) |
Place of the transaction |
Outside a Trading Venue |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in GB00B24CGK77 - ID code for ordinary shares |
||||||
|
b) |
Nature of the transaction |
Sale of shares to settle tax liabilities arising from vesting of replacement share award and dividend equivalent shares. |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information - Aggregated volume - Price |
|
||||||
|
e) |
Date of the transaction |
2025-08-01 |
||||||
|
f) |
Place of the transaction |
|
||||||
CONTACT DETAILS:
Contacts
Investor Relations
Catheryn O'Rourke +44 (0) 1753 217 800
General Counsel & Company Secretary
About Reckitt:
We make the products people trust to care for the ones they love. We are home to some of the world's best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives.
Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation.
We believe good health starts at home. With every action we take, we strive to make our consumers' lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.
* Reckitt is the trading name of the Reckitt Benckiser group of companies
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the